Latest filing published 04 Nov 2020 for Damora Therapeutics, Inc., €859k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -77.7%Entry US$375.00 · Close at T+365 US$83.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephan Christgau: trading record in brief
Stephan Christgau is a declared insider of Damora Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 2 November 2020.
On the market, this insider has only ever bought: 1 purchase, €859k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 4 November 2020, reports an open-market purchase of €859k in Damora Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephan Christgau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 66,666 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-20-030410:1Canonical exit: 31 Jan 2021 (T+90)
- 479,470 sharesCommon StockSEC:0000899243-20-030410:0
2 of 2 declarations
